Zobrazeno 1 - 10
of 960
pro vyhledávání: '"Kortmann, Rolf"'
Autor:
Gringmuth, Marieke, Walther, Jenny, Greiser, Sebastian, Touissant, Magali, Schwalm, Benjamin, Kool, Marcel, Kortmann, Rolf-Dieter, Glasow, Annegret, Patties, Ina
Children with high-risk SHH/TP53-mut and Group 3 medulloblastoma (MB) have a 5-year overall survival of only 40%. Innovative approaches to enhance survival while preventing adverse effects are urgently needed. We investigated an innovative therapy ap
Externí odkaz:
https://ul.qucosa.de/id/qucosa%3A89163
https://ul.qucosa.de/api/qucosa%3A89163/attachment/ATT-0/
https://ul.qucosa.de/api/qucosa%3A89163/attachment/ATT-0/
Autor:
Chavaz, Lara, Janssens, Geert O., Bolle, Stephanie, Mandeville, Henry, Ramos-Albiac, Monica, van Beek, Karen, Benghiat, Helen, Hoeben, Bianca, Morales La Madrid, Andres, Seidel, Clemens, Kortmann, Rolf-Dieter, Hargreave, Darren, Gandola, Lorenza, Pecori, Emilia, van Vuurden, Dannis G., Biassoni, Veronica, Massimino, Maura, Kramm, Christof M., van Bueren, Andre O.
Purpose: The aim of this study is to investigate the spectrum of neurological triad improvement in patients with diffuse intrinsic pontine glioma (DIPG) treated by reirradiation (re-RT) at first progression. Methods: We carried out a re-analysis of t
Externí odkaz:
https://ul.qucosa.de/id/qucosa%3A87689
https://ul.qucosa.de/api/qucosa%3A87689/attachment/ATT-0/
https://ul.qucosa.de/api/qucosa%3A87689/attachment/ATT-0/
Multimodal treatment adding immunotherapy and photodynamic treatment (PDT) to standard therapy might improve the devastating therapeutic outcome of glioblastoma multiforme patients. As a first step, we provide investigations to optimize dendritic cel
Externí odkaz:
https://ul.qucosa.de/id/qucosa%3A87051
https://ul.qucosa.de/api/qucosa%3A87051/attachment/ATT-0/
https://ul.qucosa.de/api/qucosa%3A87051/attachment/ATT-0/
Autor:
Seidel, Clemens, Heider, Sina, Hau, Peter, Glasow, Annegret, Dietzsch, Stefan, Kortmann, Rolf-Dieter
Medulloblastoma is the most frequent malignant brain tumor in children. During the last decades, the therapeutic landscape has changed significantly with craniospinal irradiation as the backbone of treatment. Survival times have increased and treatme
Externí odkaz:
https://ul.qucosa.de/id/qucosa%3A85087
https://ul.qucosa.de/api/qucosa%3A85087/attachment/ATT-0/
https://ul.qucosa.de/api/qucosa%3A85087/attachment/ATT-0/
Background: Primary CNS Lymphoma is a rare and severe but potentially curable disease. In the last thirty years treatment has changed significantly. Survival times increased due to high-dose methotrexate-based chemotherapy. With intensive regimens in
Externí odkaz:
https://ul.qucosa.de/id/qucosa%3A84975
https://ul.qucosa.de/api/qucosa%3A84975/attachment/ATT-0/
https://ul.qucosa.de/api/qucosa%3A84975/attachment/ATT-0/
Autor:
Hering, Kathrin, Bresch, Anke, Lobsien, Donald, Müller, Wolf, Kortmann, Rolf-Dieter, Seidel, Clemens
Publikováno v:
Case Reports in Oncological Medicine Volume 2016, Article ID 3815280, 3 pages doi: 10.1155/2016/3815280
Up to date, only four cases of primary intradural extramedullary spinal cord melanoma (PIEM) have been reported. No previous reports have described a case of PIEM located in the lower thoracic spine with long-termfollow-up. Purpose. Demonstrating an
Externí odkaz:
https://ul.qucosa.de/id/qucosa%3A14798
https://ul.qucosa.de/api/qucosa%3A14798/attachment/ATT-0/
https://ul.qucosa.de/api/qucosa%3A14798/attachment/ATT-0/
Publikováno v:
Journal of Experimental & Clinical Cancer Research (2016) 35:94 doi: 10.1186/s13046-016-0376-1
Background: Medulloblastoma (MB) is the most common pediatric brain tumor. Current treatment regimes consisting of primary surgery followed by radio- and chemotherapy, achieve 5-year overall survival rates of only about 60 %. Therapy-induced endocrin
Externí odkaz:
https://ul.qucosa.de/id/qucosa%3A14775
https://ul.qucosa.de/api/qucosa%3A14775/attachment/ATT-0/
https://ul.qucosa.de/api/qucosa%3A14775/attachment/ATT-0/
Autor:
Beyer, Stefanie, von Bueren, André O., Klautke, Gunther, Guckenberger, Matthias, Kortmann, Rolf-Dieter, Pietschmann, Sophie, Müller, Klaus
Publikováno v:
PLoS ONE 11(2): e0148312 doi:10.1371/ journal.pone.0148312
Our aim was to determine the characteristics, treatments and outcomes of patients with primary spinal glioblastomas (GB) or gliosarcomas (GS) reported in literature until March 2015. PubMed and Web of Science were searched for peer-reviewed articles
Externí odkaz:
https://ul.qucosa.de/id/qucosa%3A14746
https://ul.qucosa.de/api/qucosa%3A14746/attachment/ATT-0/
https://ul.qucosa.de/api/qucosa%3A14746/attachment/ATT-0/
Autor:
Pietschmann, Sophie, von Bueren, André O., Kerber, Michael J., Baumert, Brigitta G., Kortmann, Rolf-Dieter, Müller, Klaus
Publikováno v:
PLoS one 2015, 10(4): e0121592
To determine the characteristics, treatments and outcomes of patients with glioblastoma multiforme (GBM) or gliosarcoma (GS) and metastases outside of the central nervous system (CNS).
Externí odkaz:
https://ul.qucosa.de/id/qucosa%3A13325
https://ul.qucosa.de/api/qucosa%3A13325/attachment/ATT-0/
https://ul.qucosa.de/api/qucosa%3A13325/attachment/ATT-0/
Autor:
Schlamann, Annika, von Bueren, André, Hagel, Christian, Zwiener, Isabella, Seidel, Clemens, Kortmann, Rolf-Dieter, Müller, Klaus
Publikováno v:
Cell Death and Disease (2014) 5, e1119; doi:10.1038/cddis.2014.25
Background and Purpose: In 2007, the WHO classification of brain tumors was extended by three new entities of glioneuronal tumors: papillary glioneuronal tumor (PGNT), rosette-forming glioneuronal tumor of the fourth ventricle (RGNT) and glioneuronal
Externí odkaz:
https://ul.qucosa.de/id/qucosa%3A11681
https://ul.qucosa.de/api/qucosa%3A11681/attachment/ATT-0/
https://ul.qucosa.de/api/qucosa%3A11681/attachment/ATT-0/